The Latest Cardiac and Vascular News
Third Quarter Revenues Increase 36% to $11.0Million U.S. WatchPATTMRevenues Increase 55% to $8.9Million Full Year 2020 Revenue Guidance of $39.5 Million to $40.5 Million Company to Host Conference Call Today at 8:00am ET, 3:00pm IT CAESAREA, Israel, Nov. 17, 2020 […]
CAESAREA, Israel, Oct. 19, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the diagnosis of sleep apnea and other respiratory sleep disorders, today announced that Shane Brown has been appointed […]
Q3 Total Revenue Results of $10.7M to $11.0M, reflecting growth of 32%-36% Q3 U.S. WatchPAT Revenue Results of $8.6M to $8.9M, reflecting growth of 51%-56% Full Year 2020 Revenue Guidance of $39.5M to $40.5M CAESAREA, Israel, Oct. 13, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a leading […]
Complete, home-based solution for diagnosing respiratory sleep disorders approved for commercialization in Europe and other CE Mark geographies CAESAREA, Israel, May 04, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology company focused on the […]
– Company Ramping Up WatchPAT™ ONE Production Capacity to Meet Demand for Disposable Home Sleep Apnea Tests – CAESAREA, Israel, April 13, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the […]
Study will evaluate how raw signals from tens of thousands of WatchPAT recordings conducted over the last 10 years in combination with health medical records can be leveraged to predict cardiovascular outcomes CAESAREA, Israel, March 02, 2020 (GLOBE NEWSWIRE) — […]
CAESAREA, Israel, Feb. 04, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced […]
CAESAREA, Israel, Jan. 30, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the upsizing […]
– 2019 Fiscal Year Revenues Expected to Increase 29% to $31.1 Million to $31.3 Million – – Full Year 2020 Revenue Guidance of $39.5 Million to $42.0 Million – CAESAREA, Israel, Jan. 13, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq: ITMR) […]
– Third Quarter Revenues Increase 33% to $8.1 Million – – WatchPAT™ Revenues Increase 32% in the Third Quarter to $7.6 Million – – Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT – CAESAREA, Israel, […]
